vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and SILVERCORP METALS INC (SVM). Click either name above to swap in a different company.
SILVERCORP METALS INC is the larger business by last-quarter revenue ($223.8M vs $208.9M, roughly 1.1× iRhythm Holdings, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -1.3%, a 4.0% gap on every dollar of revenue. Over the past eight quarters, SILVERCORP METALS INC's revenue compounded faster (87.6% CAGR vs 25.8%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Silvercorp Metals Inc. (Silvercorp) is a Canadian-based, China-focused precious metals company engaged in the acquisition, exploration, and development of silver-containing properties.
IRTC vs SVM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $223.8M |
| Net Profit | $5.6M | $-2.9M |
| Gross Margin | 70.9% | — |
| Operating Margin | 1.1% | — |
| Net Margin | 2.7% | -1.3% |
| Revenue YoY | 27.1% | — |
| Net Profit YoY | 518.5% | — |
| EPS (diluted) | $0.18 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $223.8M | ||
| Q3 25 | $192.9M | — | ||
| Q2 25 | $186.7M | $72.2M | ||
| Q1 25 | $158.7M | — | ||
| Q4 24 | $164.3M | $172.5M | ||
| Q3 24 | $147.5M | $114.0M | ||
| Q2 24 | $148.0M | $60.0M | ||
| Q1 24 | $131.9M | — |
| Q4 25 | $5.6M | $-2.9M | ||
| Q3 25 | $-5.2M | — | ||
| Q2 25 | $-14.2M | $28.1M | ||
| Q1 25 | $-30.7M | — | ||
| Q4 24 | $-1.3M | $42.1M | ||
| Q3 24 | $-46.2M | $28.0M | ||
| Q2 24 | $-20.1M | $13.2M | ||
| Q1 24 | $-45.7M | — |
| Q4 25 | 70.9% | — | ||
| Q3 25 | 71.1% | — | ||
| Q2 25 | 71.2% | — | ||
| Q1 25 | 68.8% | — | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 68.8% | — | ||
| Q2 24 | 69.9% | — | ||
| Q1 24 | 66.3% | — |
| Q4 25 | 1.1% | — | ||
| Q3 25 | -4.4% | — | ||
| Q2 25 | -10.0% | — | ||
| Q1 25 | -20.5% | — | ||
| Q4 24 | -2.5% | 30.5% | ||
| Q3 24 | -34.1% | 30.7% | ||
| Q2 24 | -15.5% | 30.0% | ||
| Q1 24 | -28.9% | — |
| Q4 25 | 2.7% | -1.3% | ||
| Q3 25 | -2.7% | — | ||
| Q2 25 | -7.6% | 39.0% | ||
| Q1 25 | -19.3% | — | ||
| Q4 24 | -0.8% | 24.4% | ||
| Q3 24 | -31.3% | 24.5% | ||
| Q2 24 | -13.6% | 22.0% | ||
| Q1 24 | -34.6% | — |
| Q4 25 | $0.18 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.44 | — | ||
| Q1 25 | $-0.97 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $-1.48 | — | ||
| Q2 24 | $-0.65 | — | ||
| Q1 24 | $-1.47 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | — |
| Total Assets | $1.0B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | — | ||
| Q3 25 | $565.2M | — | ||
| Q2 25 | $545.5M | — | ||
| Q1 25 | $520.6M | — | ||
| Q4 24 | $535.6M | — | ||
| Q3 24 | $522.0M | — | ||
| Q2 24 | $561.5M | — | ||
| Q1 24 | $569.1M | — |
| Q4 25 | $152.7M | — | ||
| Q3 25 | $121.9M | — | ||
| Q2 25 | $103.7M | — | ||
| Q1 25 | $86.7M | — | ||
| Q4 24 | $90.9M | — | ||
| Q3 24 | $71.8M | — | ||
| Q2 24 | $99.2M | — | ||
| Q1 24 | $90.3M | — |
| Q4 25 | $1.0B | — | ||
| Q3 25 | $995.2M | — | ||
| Q2 25 | $964.0M | — | ||
| Q1 25 | $926.1M | — | ||
| Q4 24 | $931.4M | — | ||
| Q3 24 | $909.7M | — | ||
| Q2 24 | $919.2M | — | ||
| Q1 24 | $909.8M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $107.9M |
| Free Cash FlowOCF − Capex | $14.5M | — |
| FCF MarginFCF / Revenue | 6.9% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $107.9M | ||
| Q3 25 | $34.9M | — | ||
| Q2 25 | $27.7M | $40.0M | ||
| Q1 25 | $-7.9M | — | ||
| Q4 24 | $19.2M | $81.3M | ||
| Q3 24 | $24.3M | $57.7M | ||
| Q2 24 | $11.8M | $28.9M | ||
| Q1 24 | $-52.0M | — |
| Q4 25 | $14.5M | — | ||
| Q3 25 | $20.1M | — | ||
| Q2 25 | $17.3M | — | ||
| Q1 25 | $-17.3M | — | ||
| Q4 24 | $12.4M | — | ||
| Q3 24 | $15.5M | $33.8M | ||
| Q2 24 | $3.4M | $17.0M | ||
| Q1 24 | $-61.8M | — |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | -10.9% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 10.5% | 29.6% | ||
| Q2 24 | 2.3% | 28.3% | ||
| Q1 24 | -46.8% | — |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 5.9% | — | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 6.0% | 21.0% | ||
| Q2 24 | 5.7% | 19.8% | ||
| Q1 24 | 7.4% | — |
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.93× | ||
| Q3 24 | — | 2.06× | ||
| Q2 24 | — | 2.19× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
SVM
Segment breakdown not available.
